ATLAS / Macro Radar / Reporting / IKT

Inhibikase Therapeutics, Inc. (IKT) reporting calendar

Inhibikase Therapeutics, Inc. files periodic reports with the SEC as IKT on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open IKT market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-219641
10-K31 Dec 202526 Mar 202685 days0001193125-26-126371
10-Q30 Sep 202514 Nov 202545 days0001193125-25-283169
10-Q30 Jun 202514 Aug 202545 days0001193125-25-180899
10-Q31 Mar 202514 May 202544 days0000950170-25-071635
10-K31 Dec 202427 Mar 202586 days0000950170-25-046096
10-Q30 Sep 202414 Nov 202445 days0000950170-24-126766
10-Q30 Jun 202414 Aug 202445 days0000950170-24-097022
10-Q31 Mar 202415 May 202445 days0000950170-24-060579
10-K31 Dec 202327 Mar 202487 days0000950170-24-037160
10-Q30 Sep 202314 Nov 202345 days0000950170-23-063713
10-Q30 Jun 202314 Aug 202345 days0000950170-23-042389
10-Q31 Mar 202315 May 202345 days0000950170-23-021974
10-K31 Dec 202231 Mar 202390 days0000950170-23-011133
10-Q30 Sep 202214 Nov 202245 days0000950170-22-025011
10-Q30 Jun 202212 Aug 202243 days0000950170-22-017140
10-Q31 Mar 202216 May 202246 days0000950170-22-010085
10-K31 Dec 202131 Mar 202290 days0000950170-22-005203
10-Q30 Sep 202115 Nov 202146 days0000950170-21-004620
10-Q30 Jun 202116 Aug 202147 days0001564590-21-044637
10-Q31 Mar 202117 May 202147 days0001564590-21-028436
10-K31 Dec 202031 Mar 202190 days0001564590-21-016996

Source: SEC EDGAR company submissions for CIK 0001750149. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.